Works matching IS 00207136 AND DT 2024 AND VI 155 AND IP 1


Results: 20
    1
    2
    5
    6

    Efficacy and safety of everolimus plus exemestane in patients with hormone receptor‐positive, HER‐2‐negative advanced breast cancer: Results from the open‐label, multicentre, non‐interventional BRAWO study.

    Published in:
    International Journal of Cancer, 2024, v. 155, n. 1, p. 128, doi. 10.1002/ijc.34912
    By:
    • Lüftner, Diana;
    • Schuetz, Florian;
    • Schneeweiss, Andreas;
    • Hartkopf, Andreas;
    • Bloch, Wilhelm;
    • Decker, Thomas;
    • Uleer, Christoph;
    • Stötzer, Oliver;
    • Foerster, Frank;
    • Schmidt, Marcus;
    • Mundhenke, Christoph;
    • Tesch, Hans;
    • Jackisch, Christian;
    • Fischer, Thomas;
    • Kreuzeder, Julia;
    • Guderian, Gernot;
    • Fasching, Peter A.
    Publication type:
    Article
    7
    8
    9

    Targeted DNA sequencing of high‐grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression.

    Published in:
    International Journal of Cancer, 2024, v. 155, n. 1, p. 104, doi. 10.1002/ijc.34908
    By:
    • Holý, Petr;
    • Hlaváč, Viktor;
    • Šeborová, Karolína;
    • Šůsová, Simona;
    • Tesařová, Tereza;
    • Rob, Lukáš;
    • Hruda, Martin;
    • Bouda, Jiří;
    • Bartáková, Alena;
    • Mrhalová, Marcela;
    • Kopečková, Kateřina;
    • Al Obeed Allah, Mohammad;
    • Špaček, Jiří;
    • Sedláková, Iva;
    • Souček, Pavel;
    • Václavíková, Radka
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Issue Information.

    Published in:
    International Journal of Cancer, 2024, v. 155, n. 1, p. 1, doi. 10.1002/ijc.34590
    Publication type:
    Article